Use of Postbiotic as Adjunct Treatment for Vaginal Candidiasis in Women
Status: Recruiting
Location: See all (2) locations...
Intervention Type: Device
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY
This project aims to study the efficacy of intravaginal administration of postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks compared to placebo.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 81
Healthy Volunteers: f
View:
• Women who are sexually active
• Confirmed with candidiasis as confirmed via clinical observations which include creamy whitish vaginal discharge and vulva-vaginal itchiness
• Willing to commit throughout the experiment
Locations
Other Locations
India
Sumita Hospital
RECRUITING
Lucknow
Malaysia
AIMST University
NOT_YET_RECRUITING
Bedong
Contact Information
Primary
Sumita Bhatia, MD
bhatiadrsumita@gmail.com
91923569755
Backup
Min Tze Liong, PhD
mintze.liong@usm.my
604 653 2114
Time Frame
Start Date: 2024-06-02
Estimated Completion Date: 2025-06-02
Participants
Target number of participants: 118
Treatments
Experimental: Postbiotic
Postbiotic at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks
Placebo_comparator: Placebo
Placebo at 1g/day as an adjunct treatment against vaginal candidiasis in women for 4-weeks
Related Therapeutic Areas
Sponsors
Collaborators: Sumita Hospital, AIMST University
Leads: Min-Tze LIONG